000			02002 a2200601 4500
005			20250515032041.0
264		0	_c20061017
008			200610s 0 0 eng d
022			_a0007-0963
024	7		_a10.1111/j.1365-2133.2006.07316.x _2doi
040			_aNLM _beng _cNLM
100	1		_aSmith, C H
245	0	0	_aInfliximab for severe, treatment-resistant psoriasis: a prospective, open-label study. _h[electronic resource]
260			_bThe British journal of dermatology _cJul 2006
300			_a160-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAbscess _xetiology
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAutoantibodies _xblood
650	0	4	_aCarcinoma, Basal Cell _xetiology
650	0	4	_aCarcinoma, Renal Cell _xetiology
650	0	4	_aCellulitis _xetiology
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aHypertension _xetiology
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aInfliximab
650	0	4	_aKidney Neoplasms _xetiology
650	0	4	_aLentigo _xetiology
650	0	4	_aLiver Diseases _xetiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aRespiratory Tract Infections _xetiology
650	0	4	_aSkin Neoplasms _xetiology
650	0	4	_aThrombocytopenia _xetiology
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTuberculosis _xetiology
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
700	1		_aJackson, K
700	1		_aBashir, S J
700	1		_aPerez, A
700	1		_aChew, A L
700	1		_aPowell, A M
700	1		_aWain, M
700	1		_aBarker, J N W N
773	0		_tThe British journal of dermatology _gvol. 155 _gno. 1 _gp. 160-9
856	4	0	_uhttps://doi.org/10.1111/j.1365-2133.2006.07316.x _zAvailable from publisher's website
999			_c16386382 _d16386382